These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 4377908)
21. Serum immunoglobulin concentrations in human S. mansoni and S. haematobium infections in the Sudan, with special reference to the effect of chemotherapy. Salih SY; Voller A; Woodruff AW Tropenmed Parasitol; 1978 Sep; 29(3):269-74. PubMed ID: 726042 [TBL] [Abstract][Full Text] [Related]
22. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni. Haese WH; Bueding E J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276 [TBL] [Abstract][Full Text] [Related]
24. Hycanthone methanesulfonate (etrenol) in the treatment of S. mansoni. Ongom VL East Afr Med J; 1971 Jun; 48(6):247-50. PubMed ID: 5136919 [No Abstract] [Full Text] [Related]
25. A study of the mode of action of hycanthone against Schistosoma mansoni in vivo and in vitro. Cioli D; Knopf PM Am J Trop Med Hyg; 1980 Mar; 29(2):220-6. PubMed ID: 7369442 [TBL] [Abstract][Full Text] [Related]
26. Biochemical studies on beta-glucuronidase in the urinary bladder of normal and Schistosoma mansoni infected mice treated with hycanthone. Saad AA; El-Zoghby SM; Farag HF; el-Sewedy SM; Girgis LH; Moghazy M Acta Vitaminol Enzymol; 1977; 31(6):183-6. PubMed ID: 581137 [TBL] [Abstract][Full Text] [Related]
27. Therapeutic evaluation of hycanthone in school children in rural endemic area in Egypt. Mousa AH; El-Abdin AZ; El-Garem AA; El-Raziky EH; Fadl AA Egypt J Bilharz; 1974; 1(1):65-83. PubMed ID: 4469236 [No Abstract] [Full Text] [Related]
28. [Hycanthone in a single intramuscular dose. Therapeutic results obtained in subjects excreting S. mansoni eggs and treated at Kapolowe (region of the artificial lake of Lufira, Republic of Zaire)]. Raccurt C; Grimaud JA; Ripert C Bull Soc Pathol Exot Filiales; 1974; 67(4):425-35. PubMed ID: 4480532 [No Abstract] [Full Text] [Related]
29. A review of the clinical pharmacology of hycanthone. Dennis EW; Kobus W Egypt J Bilharz; 1974; 1(1):35-53. PubMed ID: 4619885 [No Abstract] [Full Text] [Related]
30. Hycanthone in experimental schistosomiasis studies on liver pathology in mice treated with one and two doses. Farag HF; Guirguis RS; Sherif A; Hanna AT J Egypt Med Assoc; 1976; 59(5-6):439-47. PubMed ID: 1032313 [No Abstract] [Full Text] [Related]
31. [Treatment of schistosomiasis using hycanthone in 246 children. Side effects, laboratory studies and efficacy of various doses]. Soares D; Guimarães RX; Domingues SH; de Pádua Vilela M AMB Rev Assoc Med Bras; 1975 Mar; 21(3):89-91. PubMed ID: 1079617 [No Abstract] [Full Text] [Related]
32. The effect of a second dose of hycanthone alone and with progesterone caproate on the cure rate and the side reactions of hycanthone in the treatment of S. haematobium infected cases. El-Abdin AZ; Samy G; Mousa AH; El-Raziky EH; Roshdy MZ; Abd-El-Rahman H; Hafez S; Adham IA Egypt J Bilharz; 1974; 1(1):117-33. PubMed ID: 4619883 [No Abstract] [Full Text] [Related]
33. Control of Schistosoma mansoni transmission by chemotherapy in St. Lucia. I. Results in man. Cook JA; Jordan P; Bartholomew RK Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):887-93. PubMed ID: 907051 [TBL] [Abstract][Full Text] [Related]
34. Hycanthone dose-response in Schistosoma mansoni infection in Kenya. Warren KS; Siongok TK; Ouma JH; Houser HB Lancet; 1978 Feb; 1(8060):352-4. PubMed ID: 75394 [TBL] [Abstract][Full Text] [Related]
35. [Resistance to hycanthone and oxamniquine in patients with a clinical hepato-intestinal form of schistosomiasis]. Guimarães RX; Tchakerian A; Dias LC; de Almeida FM; Vilela MP; Cabeca M; Takeda AK AMB Rev Assoc Med Bras; 1979 Feb; 25(2):48-50. PubMed ID: 314642 [No Abstract] [Full Text] [Related]
36. Hycanthone dose-response in treatment of schistosomiasis mansoni in St. Lucia. Cook JA; Jordan P; Armitage P Am J Trop Med Hyg; 1976 Jul; 25(4):602-7. PubMed ID: 961979 [TBL] [Abstract][Full Text] [Related]
37. An assessment of anti-schistosomal treatment on physical work capacity. Awad El Karim MA; Collins KJ; Sukkar MY; Omer AH; Amin MA; Doré C J Trop Med Hyg; 1981 Apr; 84(2):67-72. PubMed ID: 7218405 [TBL] [Abstract][Full Text] [Related]
38. Hycanthone: a review of its experimental chemotherapy, pharmacology and toxicology. Farah A; Berberian DA; Davison C; Dennis EW; Donikian MA; Drobeck HP; Ferrari RA; Yarinsky A Egypt J Bilharz; 1974; 1(2):181-95. PubMed ID: 4220100 [No Abstract] [Full Text] [Related]
39. [Letter: 3 deaths following administration of hycanthone (Etrenol)]. Stolte JB Ned Tijdschr Geneeskd; 1976 May; 120(18):795-6. PubMed ID: 1264278 [No Abstract] [Full Text] [Related]
40. Fatal hepatic necrosis in association with hycanthone. Hatchuel W S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]